Effects of tibolone on the quality of life, anxiety-depression levels and cognitive functions in natural menopause: An observational follow-up study

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 45, Issue 1, 2005, Pages 71-73

  Gülseren, Leyla ^a,b   Kalafat, Devrim ^a   Mandaci, Hatice ^a   Gülseren, Şeref ^a   Çamli, Lütfü ^a  

^a Ataturk Research and Training State Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Anxiety depression; Cognitive functions; Natural menopause; Quality of life; Tibolone

Indexed keywords

TIBOLONE;

ADULT; ANXIETY DISORDER; ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; MENTAL HEALTH; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE; VAGINA BLEEDING;

ANXIETY; COGNITION; DEPRESSION; ESTROGEN RECEPTOR MODULATORS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MENOPAUSE; MIDDLE AGED; NORPREGNENES; QUALITY OF LIFE;

EID: 15844406173     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2005.00345.x     Document Type: Article

References (14)

1. Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol. 2001; 185: 13-23.
2. Wiklund I, Holst J, Karlberg J, Mattsson LA, Samsioe G, Sandin K et al. A new methodological approach to the evaluation of quality of life in post menopausal women. Maturitas 1992; 14: 211-224.
3. Roussouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative and randomized controlled trial. JAMA 2002; 288: 321-333.
4. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004; 291: 1701-1712.
5. Ginsburg J, Prevelic GM. The place of tibolone in menopausal therapy. In: Studd J (ed). The Management of the Menopause: the Millennium Review. London: Parthenon Publishing, 2000; 59-67.
6. Speroff L, Glass RH, Kase NG, eds. Clinical Gynecologic Endocrinology and Infertility. Baltimore, Lippincott: Williams & Wilkins, 1999.
7. Akdemir A, Örsel SD, Dag Y, Türkçapar H, Iscan N, Özbay H. Clinical use and reliability and validity of the Turkish version of the Hamilton Depression Rating Scale (HDRS). J Psychiatry Psychol Psychopharmacology 1996; 4: 251-259 (Turkish).
8. Yazici MK, Demir B, Tanriverdi N, Karaagaoglu E, Yolaç P. Hamilton Anxiety Rating Scale. Interrater Reliability and Validity Study. Turk Psikiyatri Derg 1998; 9: 114-117 (Turkish).
9. Koçyiǧit H, Aydemir Ö, Fisek G, Memis A. Validity and reliability of Turkish version of Short Form-36 (SF-36). Turkish J Drug Therapeutics 1999; 12: 102-106.
10. Kaplan I. Mental disorders and disability in a primary health care clinic in semi-rural area. Turk Psikiyatri Derg 1995; 6: 169-179 (Turkish).
11. Uçanok Z, Bayraktar R. Menopausal symptoms, attitudes towards menopause and life orientation in women at different age groups and educational levels. J. Psychiatry, Psychol Psychopharmacol. 1996; 4: 11-20 (Turkish).
12. Ormanoǧlu UM, Özgüzel M. Evaluation of patients with memory disorders from different diagnosis groups with Wechsler Memory Scale. In: Unal M (ed). The Book of XXI. Congress of Psychiatric and Neurological Sciences. Adana: Publishment of Çukurova University, 1985; 228-233.
13. Öktem ÖA. Verbal test of memory processes. Arch. Neuropsychiatr 1992; 29: 196-206 (Turkish).
14. Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy. Climacteric, 2001; 4: 314-319.